Switch to:

Denali Therapeutics Equity-to-Asset

: 0.73 (As of Sep. 2019)
View and export this data going back to 2017. Start your Free Trial

Equity to Asset ratio is calculated as shareholder's tangible equity divided by its total asset. Denali Therapeutics's Total Stockholders Equity for the quarter that ended in Sep. 2019 was $438.2 Mil. Denali Therapeutics's Total Assets for the quarter that ended in Sep. 2019 was $603.0 Mil. Therefore, Denali Therapeutics's Equity to Asset Ratio for the quarter that ended in Sep. 2019 was 0.73.

NAS:DNLI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.73   Max: 0.88
Current: 0.73

0.73
0.88

During the past 4 years, the highest Equity to Asset Ratio of Denali Therapeutics was 0.88. The lowest was 0.73. And the median was 0.83.

NAS:DNLI's Equity-to-Asset is ranked higher than
64% of the 764 Companies
in the Biotechnology industry.

( Industry Median: 0.66 vs. NAS:DNLI: 0.73 )

Denali Therapeutics Equity-to-Asset Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
Equity-to-Asset 0.00 0.00 0.00 0.83

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Equity-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.83 0.76 0.75 0.73

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Denali Therapeutics Equity-to-Asset Distribution

* The bar in red indicates where Denali Therapeutics's Equity-to-Asset falls into.



Denali Therapeutics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing shareholder's tangible equity divided by its total asset.

Denali Therapeutics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2018 is calculated as

Equity to Asset (A: Dec. 2018 )=Total Stockholders Equity/Total Assets
=546.845/661.984
=0.83

Denali Therapeutics's Equity to Asset Ratio for the quarter that ended in Sep. 2019 is calculated as

Equity to Asset (Q: Sep. 2019 )=Total Stockholders Equity/Total Assets
=438.197/602.978
=0.73

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Denali Therapeutics  (NAS:DNLI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Denali Therapeutics Equity-to-Asset Related Terms


Denali Therapeutics Equity-to-Asset Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)